CY2019042I2 - Οφθαλμολογικες συνθεσεις και η χρηση τους - Google Patents

Οφθαλμολογικες συνθεσεις και η χρηση τους

Info

Publication number
CY2019042I2
CY2019042I2 CY2019042C CY2019042C CY2019042I2 CY 2019042 I2 CY2019042 I2 CY 2019042I2 CY 2019042 C CY2019042 C CY 2019042C CY 2019042 C CY2019042 C CY 2019042C CY 2019042 I2 CY2019042 I2 CY 2019042I2
Authority
CY
Cyprus
Prior art keywords
ophthalmic compositions
ophthalmic
compositions
Prior art date
Application number
CY2019042C
Other languages
English (en)
Other versions
CY2019042I1 (el
Original Assignee
Laboratoires Thea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Thea filed Critical Laboratoires Thea
Publication of CY2019042I2 publication Critical patent/CY2019042I2/el
Publication of CY2019042I1 publication Critical patent/CY2019042I1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Surgery (AREA)
  • Neurosurgery (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CY2019042C 2005-03-09 2019-11-05 Οφθαλμολογικες συνθεσεις και η χρηση τους CY2019042I1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0502357A FR2882930B1 (fr) 2005-03-09 2005-03-09 Nouvelles compositions ophtalmologiques et leur mode d'utilisation
PCT/FR2006/000528 WO2006095095A1 (fr) 2005-03-09 2006-03-09 Compositions ophtalmologiques et leur mode d’utilisation

Publications (2)

Publication Number Publication Date
CY2019042I2 true CY2019042I2 (el) 2020-05-29
CY2019042I1 CY2019042I1 (el) 2020-05-29

Family

ID=35058756

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20191100828T CY1121865T1 (el) 2005-03-09 2019-08-05 Οφθαλμολογικες συνθεσεις και η χρηση τους
CY2019042C CY2019042I1 (el) 2005-03-09 2019-11-05 Οφθαλμολογικες συνθεσεις και η χρηση τους

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20191100828T CY1121865T1 (el) 2005-03-09 2019-08-05 Οφθαλμολογικες συνθεσεις και η χρηση τους

Country Status (27)

Country Link
US (2) US20080194649A1 (el)
EP (1) EP1858481B1 (el)
JP (1) JP2008532985A (el)
KR (1) KR20070111501A (el)
CN (1) CN101151018A (el)
BE (1) BE2019C013I2 (el)
CA (1) CA2598503C (el)
CY (2) CY1121865T1 (el)
DK (1) DK1858481T3 (el)
ES (1) ES2728071T3 (el)
FR (2) FR2882930B1 (el)
HR (1) HRP20191044T1 (el)
HU (1) HUE043668T2 (el)
IL (1) IL185197A0 (el)
LT (2) LT1858481T (el)
LU (1) LUC00136I2 (el)
MA (1) MA29269B1 (el)
MX (1) MX2007010295A (el)
NL (1) NL301017I2 (el)
NO (2) NO339793B1 (el)
PL (1) PL1858481T3 (el)
PT (1) PT1858481T (el)
RU (1) RU2392925C2 (el)
SI (1) SI1858481T1 (el)
TN (1) TNSN07343A1 (el)
TR (1) TR201908487T4 (el)
WO (1) WO2006095095A1 (el)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8602959B1 (en) * 2010-05-21 2013-12-10 Robert Park Methods and devices for delivery of radiation to the posterior portion of the eye
BR112013021048A2 (pt) * 2011-02-18 2016-10-18 M S Appasmy Associates composição oftálmica para permitir dilatação de pupilas
ITPA20110004A1 (it) * 2011-02-23 2012-08-24 Francesco Paolo Montalto Iniezione intracamerulare per anestesia e dilatazione pupillare (midriasi).
CN103159672A (zh) * 2012-07-16 2013-06-19 湖南尔文生物科技有限公司 一种托品酰胺的制备方法
AU2013201465B2 (en) 2012-10-24 2016-03-03 Rayner Intraocular Lenses Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
RU2525512C1 (ru) * 2013-03-28 2014-08-20 федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации Способ медикаментозного расширения ригидного зрачка перед проведением факоэмульсификации
US20210346318A1 (en) * 2013-10-03 2021-11-11 Harrow Ip, Llc Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
AU2014329412B2 (en) * 2013-10-03 2020-02-27 Harrow Ip, Llc Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
CN105213418B (zh) * 2015-11-11 2019-01-22 中国人民解放军第四军医大学 一种眼科术前用复方滴眼液及其制备方法
KR20190035927A (ko) 2016-08-25 2019-04-03 임프리미스 파마슈티컬스, 인크. 안구 내 투여를 위한 에피네프린-기반 안과용 조성물 및 이의 제조방법
RU2649534C1 (ru) * 2017-05-10 2018-04-03 Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия непрерывного профессионального образования" Министерства здравоохранения Российской Федерации (ФГБОУ ДПО РМАНПО Минздрава России) Способ анестезии при факоэмульсификации катаракты
RU2662423C1 (ru) * 2017-07-26 2018-07-25 Федеральное государственное автономное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации Способ проведения обезболивания при выполнении витреоретинальных операций
AU2020245203A1 (en) * 2019-03-26 2021-11-11 Martin Uram Anesthetic composition and method of anesthetizing the eye

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3026323A (en) * 1960-03-22 1962-03-20 Rubin J Schacter Salts of tribasic acids
US4738851A (en) * 1985-09-27 1988-04-19 University Of Iowa Research Foundation, Inc. Controlled release ophthalmic gel formulation
JPH0780760B2 (ja) * 1986-07-28 1995-08-30 ライオン株式会社 安定化されたフエニレフリン系液剤
JP3066561B2 (ja) * 1993-10-07 2000-07-17 武田薬品工業株式会社 近視予防・治療剤
US5686414A (en) * 1995-11-14 1997-11-11 Xoma Corporation Methods of treating conditions associated with corneal transplantation
US5779661A (en) * 1995-12-11 1998-07-14 Physion, S.R.L. Method of treating dysfunctional bladder syndromes by electromotive drug administration
US6319240B1 (en) * 1999-05-25 2001-11-20 Iomed, Inc. Methods and apparatus for ocular iontophoresis
EP1233811A2 (en) * 1999-11-12 2002-08-28 Leo Rubin Methods for treating cardiac arrest or pulmonary hypertension and compositions for use therein comprising vasoactive intestinal polypeptide and cardiac device for electrical and chemical regulation and methods of use
US6218428B1 (en) * 2000-04-28 2001-04-17 Emil Chynn Ophthalmic composition
JP4150846B2 (ja) * 2001-03-28 2008-09-17 参天製薬株式会社 ステロイドを有効成分とする網脈絡膜疾患治療剤
RU2183115C1 (ru) * 2001-06-29 2002-06-10 Государственное унитарное предприятие Межбольничная аптека Медицинского центра Управления делами Президента Российской Федерации Фармацевтическая композиция, обладающая спазмолитическим и анальгезирующим действием
US20040013729A1 (en) * 2002-07-18 2004-01-22 Buono Lawrence M. Single-drop multiple-agent composition for topical delivery to the eye
CN103143022A (zh) * 2002-07-30 2013-06-12 奥默罗斯公司 眼科冲洗液及方法

Also Published As

Publication number Publication date
LTPA2019017I1 (lt) 2019-12-10
NO20074850L (no) 2007-09-24
BRPI0607416A2 (pt) 2009-09-08
ES2728071T3 (es) 2019-10-22
CY1121865T1 (el) 2020-05-29
NL301017I1 (nl) 2019-11-06
NO2017008I2 (no) 2017-03-24
EP1858481A1 (fr) 2007-11-28
BE2019C013I2 (el) 2025-12-03
SI1858481T1 (sl) 2019-08-30
LUC00136I2 (el) 2021-02-12
US20120220637A1 (en) 2012-08-30
KR20070111501A (ko) 2007-11-21
FR19C1066I1 (fr) 2019-12-20
US20080194649A1 (en) 2008-08-14
JP2008532985A (ja) 2008-08-21
LT1858481T (lt) 2019-07-10
NO339793B1 (no) 2017-01-30
CN101151018A (zh) 2008-03-26
RU2392925C2 (ru) 2010-06-27
NO2017008I1 (no) 2017-03-24
FR19C1066I2 (fr) 2021-01-08
RU2007137115A (ru) 2009-04-20
US9289399B2 (en) 2016-03-22
CA2598503C (fr) 2014-01-28
TNSN07343A1 (fr) 2008-12-31
FR2882930A1 (fr) 2006-09-15
FR2882930B1 (fr) 2009-03-27
TR201908487T4 (tr) 2019-07-22
LUC00136I1 (el) 2019-11-04
HUE043668T2 (hu) 2019-08-28
MX2007010295A (es) 2007-12-11
CY2019042I1 (el) 2020-05-29
EP1858481B1 (fr) 2019-05-08
DK1858481T3 (da) 2019-06-03
CA2598503A1 (fr) 2006-09-14
MA29269B1 (fr) 2008-02-01
PT1858481T (pt) 2019-06-14
WO2006095095A1 (fr) 2006-09-14
NL301017I2 (nl) 2020-04-30
IL185197A0 (en) 2008-01-06
PL1858481T3 (pl) 2019-09-30
HRP20191044T1 (hr) 2019-09-06

Similar Documents

Publication Publication Date Title
CY2019042I1 (el) Οφθαλμολογικες συνθεσεις και η χρηση τους
CY2025024I1 (el) Βελτιωμενα επιλεκτικα πρωτοϊνιδιων αντισωματα και η χρηση αυτων
CY2017006I2 (el) Αερολυμενες φθοροκινολονες και χρησεις αυτων
CY2018013I1 (el) Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
DK1811959T4 (da) Oftalmiske sammensætninger
DK3295967T3 (da) Sårplejeindretning
EP1926449A4 (en) DENTAL UNIT
EP1857091A4 (en) COSMETIC
BRPI0613033A2 (pt) composição oral
DK1988877T3 (da) Terapeutiske sammensætninger omfattende ingenol-3-angelat
EP1893244A4 (en) AGENTS FOR IMAGING
DE602005008726D1 (de) Verwendet
ATE510595T1 (de) Haarbehandlungszusammensetzungen
ATE504334T1 (de) Haarbehandlungszusammensetzungen
FR2885520B1 (fr) Composition cosmetique
DE602006006937D1 (de) Hosenträger
FR2881342B1 (fr) Composition demaquillante
FI20041641L (fi) Sovitelma silmänpainemittarissa
DE602006011271D1 (de) Anthelminthische zusammensetzung
FR2885521B1 (fr) Composition cosmetique
BRPI0620807A2 (pt) dentifrício
BRPI0620820A2 (pt) dentifrício
ITBO20050375A1 (it) Riunito dentale
FI20050453A0 (fi) Ihonhoitokoostumus
NO20052428D0 (no) Kontrastmidler